Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Cell Host & Microbe|November 20, 2012
Defining a healthy human gut microbiome: current concepts, future directions, and clinical applicationsFredrik Bäckhed, Claire M Fraser, Yehuda Ringel, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|May 5, 2006
Mechanisms of disease: the hygiene hypothesis revisitedFrancisco Guarner, Raphaëlle Bourdet-Sicard, Per Brandtzaeg, et al.
JAAPA : Official Journal of the American Academy of Physician Assistants|September 28, 2021
Screening pediatric surgical patients during the COVID-19 pandemicRami P Dibbs, Andrew M Ferry, Steven C Mehl, et al.
Infection Control and Hospital Epidemiology|December 17, 2009
Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007Kristina G Hultén, Sheldon L Kaplan, Linda B Lamberth, et al.
Clinical and Translational Science|January 20, 2022
Peppermint oil effects on the gut microbiome in children with functional abdominal painSantosh Thapa, Ruth Ann Luna, Bruno P Chumpitazi, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 10, 2017
Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum DisorderRuth Ann Luna, Numan Oezguen, Miriam Balderas, et al.
Gut Microbes|March 19, 2014
Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndromeBruno P Chumpitazi, Emily B Hollister, Numan Oezguen, et al.
Frontiers in Microbiology|October 26, 2019
Microbial Metabolic Capacity for Intestinal Folate Production and Modulation of Host Folate ReceptorsMelinda A Engevik, Christina N Morra, Daniel Röth, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 16, 2016
Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind TrialRobert J Shulman, Emily B Hollister, Kevin Cain, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2008
Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolatesLauren Becnel Boyd, Merry J Maynard, Sonia K Morgan-Linnell, et al.
Pageof 16